Global left ventricular performance in non-diabetic non-hypertensive metabolic syndrome adults

Table 2 Echocardiographic data in both case and control groups (mean±SD)

Characteristics	Controls (n = 34)	Group A (n = 59)	Group B (n = 97)	P	P1	P2
End SD (mm)	28.8 ± 1.5	29.1 ± 1.4	28.8 ± 1.4	NS	NS	NS
End DD (mm)	48.7 ± 4.6	50.6 ± 4.4	49.9 ± 4.5	NS	NS	NS
EF (%)	63.9 ± 7.9	63.5 ± 6.5	62.7 ± 7.4	NS	NS	NS
IVS thickness (mm)	8.6 ± 0.5	8.4 ± 0.6	9.2 ± 0.7	NS	< 0.05	NS
PW thickness (mm)	8.6 ± 0.7	8.6 ± 0.6	9.3 ± 0.9	NS	< 0.05	NS
RWT (%)	36.3 ± 3.6	37.9 ± 3.8	47.7 ± 5.8	NS	< 0.05	< 0.05
LVMI (g/m2)	88.2 ± 7.4	93.2 ± 4.1	120.8 ± 26.8	NS	< 0.05	< 0.01
E/A ratio	1.41 ± 0.19	1.26 ± 0.12	1.17 ± 0.08	NS	< 0.01	< 0.05
Tei index	0.36 ± 0.07	0.64 ± 0.17	0.87 ± 0.12	< 0.01	< 0.001	NS

End SD: End systolic diameter; End DD: End diastolic diameter; EF: Ejection fraction; IVS: Interventricular septum; PW: Posterior wall; RWT: Relative wall thickness; LVMI: Left ventricular mass index; E: E velocity; A: A velocity; P: Comparison between group A and control; P¹: Comparison between group B and control; P²: Comparison between group A and B.